Cardiometabolic Health Congress

Healio brings you the highlights from the Cardiometabolic Health Congress. Refer back to this page often for the latest news from CMHC, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

Guidelines fall short in diagnosing labile hypertension, addressing adherence

October 22, 2019
CHICAGO — There are a number of gaps in the 2017 American Heart Association/American College of Cardiology hypertension guideline that…
Meeting News

Canagliflozin ‘not your mother’s diabetes lowering drug’ due to kidney benefits

October 21, 2019
CHICAGO — The protective benefits for the kidney and cardiovascular system from SGLT2 inhibitor therapy may be more critical than the more…
Meeting News

Top takeaways from CMHC 2019

October 19, 2019
Endocrine Today has compiled a list of the top five news reports posted from the Cardiometabolic Health Congress, held from Oct. 10 to 13 in Chicago…
Meeting News

Despite new guidelines, CVD prevention barriers remain for some patients

October 16, 2019
CHICAGO — Updated guidelines provide clear CVD prevention strategies for most patients, but barriers to optimal treatment in some patients…
Meeting NewsPerspective

Simultaneous combination therapy shows major potential in type 2 diabetes

October 15, 2019
CHICAGO — When treating patients with type 2 diabetes, physicians may have more success if they use simultaneous combination therapy…
Meeting News

THEMIS, TWILIGHT, other major trials spotlighted at CMHC

October 15, 2019
CHICAGO — Healio presents live updates from the late-breaking trials session at the Cardiometabolic Health Congress. Presenters highlighted…
Meeting News

Metabolic syndrome may play role in HFpEF risk

October 14, 2019
CHICAGO — Patients with metabolic syndrome are at risk for developing HF with preserved ejection fraction, although the mechanisms behind this…
Meeting News

Lp(a) has strong effect on CVD risk

October 14, 2019
CHICAGO — Lipoprotein(a) has been shown to be an independent, causal and genetic risk factor for CVD, with higher prevalence in patients of…
Meeting News

Statin intolerance can be fought with intermittent dosing

October 14, 2019
CHICAGO —Intermittent statin dosing is a treatment option that may have tremendous potential for addressing patients with statin intolerance…
Meeting NewsVideo

VIDEO: Potassium-binding agents help enable tolerance of HF medications

October 13, 2019
CHICAGO — In this video exclusive, Cardiology Today Editorial Board Member Ileana L. Piña, MD, MPH, discussed her Cardiometabolic Health…